Recurrent Laryngeal Neuropathy (RLN)
Gene or Region: ECA3
Reference Variant: T
Mutant Variant: C
Affected Breeds: Many
Research Confidence: High - Strong correlation in larger studies
Explanation of Results: RLN/RLN = homozygous for Recurrent Laryngeal Neuropathy Risk, ~12x higher risk than n/n RLN/n = heterozygous for Recurrent Laryngeal Neuropathy Risk, ~5x higher risk than n/n n/n = no variant detected
General Information
Recurrent Laryngeal Neuropathy (RLN) commonly called "Roaring" is a disease that results in loss of the neurons that open the larynx. Although we do not know what causes RLN, it significantly affects performance in Thoroughbreds and other sport horses. In technical terms, RLN represents a distal axonopathy of the recurrent laryngeal nerves, which is tpically expressed only on the left side of the larynx (the left nerve is the longest nerve in horses). RLN is also a mononeuropathy, as other peripheral nerves of the horse remain unaffected. RLN is an important issue for horses in competitive events, because the resultant paralysis of the larynx leads to obstruction of air flow during intense exercise. This obstruction creates the abnormal inspiratory noise that gives RLN its common name: “roaring.” Horses with RLN cannot breath normally at speed and as a result don't perform to their full potential. RLN has particular economic importance in Thoroughbred racehorses because these animals enter race training as 2-year-olds. Even though many thoroughbred horses sold at auction are endoscopically examined for evidence of RLN, the condition tends to develop with age, and may not yet be clinically evident in young animals.
A genetic contribution to the pathogenesis of RLN was previously suggested by the higher prevalence of the condition in offspring of RLN-affected than unaffected stallions. A 2014 study concluded that geldings are at higher risk than mares or stallions, and noted association to a site in the genome that also contributes to height.
References
Boyko et al., “Genomic analysis establishes correlation between growth and laryngeal neuropathy in Thoroughbreds.” (2014) BMC Genomics. 15:259. PMID: 24707981
Figure 1 from: “Equine Welfare during Exercise: An Evaluation of Breathing, Breathlessness and Bridles”, Mellor and Beausoleil, Animals 2017, 7(6), 41; doi:10.3390/ani7060041
More Horse Health
Polysaccharide Storage Myopathy
Polysaccharide Storage Myopathy (PSSM) is a glycogen storage disorder in which affected horses have chronic episodes of exertional rhabdomyolysis (“tying-up”). Acute symptoms are an unwillingness to move and muscle damage following exercise. Moderate symptoms can usually be managed through a low-sugar/starch diet and exercise.
Severe Combined Immunodeficiency
Severe Combined Immunodeficiency Disease (SCID) is a condition in which affected foals are unable to mount an effective immune response after infection and are unable to recover from infections that unaffected foals would easily resist. The disease is universally fatal in horses, usually within 4-6 months of life.
West Nile Virus Symptom Susceptibility / Risk
West Nile Virus (WNV) is a mosquito-borne virus that can infect multiple types of mammals, including horses. Infection can lead to a series of severe symptoms, most commonly encephalitis – acute inflammation of the brain. Severe neurological symptoms develop in ~8% of exposed horses, and once symptoms manifest, the fatality rate ranges from 20-40% and is higher in older horses.